Jennifer Anklesaria

Jennifer Anklesaria has a diverse work experience in the regulatory operations field. Jennifer is currently working at Halozyme, Inc. as the Director of Regulatory Operations, a position they have held since October 2022. Prior to this role, Jennifer worked at Halozyme as the Associate Director of Regulatory Operations from December 2020 to October 2022.

Before joining Halozyme, Jennifer had a long tenure at PAREXEL. Jennifer started as a Consultant in PAREXEL Regulatory Outsourcing Services in November 2015 and progressed to become a Principle Associate in the same department, responsible for program management, planning, and business development support. Jennifer then took on the role of Project Leader in the Regulatory Center of Excellence from November 2017 to May 2018 and later became an Associate Program Director from June 2018 to December 2020.

Earlier in their career, Jennifer worked at Allergan as a Senior Regulatory Publisher from January 2008 to March 2013 and as a Senior Information Specialist from May 2000 to January 2008. Jennifer began their professional journey at ARCADIS JSA, where they held various positions including Project Assistant, Data Management and Administrative Assistant, Marketing Coordinator from 1998 to 2000.

Overall, Jennifer Anklesaria has demonstrated expertise in regulatory operations through their progressive roles and contributions to organizations in the pharmaceutical industry.

Jennifer Anklesaria completed their bachelor's degree in Natural Science, with a focus on Biology and Chemistry, at Concordia University-St. Paul from 1995 to 1998. Jennifer also obtained additional certifications in Clinical Trials Administration from the University of California Extension in San Diego, California, in the spring of 2003, and in Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). The specific months or years of obtaining these certifications are not provided.